Date: 2023-11-09Category: Not ApplicableState: Union GovernmentCountry: Europe
Decision of the EEA Joint Committee No 91/2023 of 28 April 2023 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/2246]
Executive Summary:
EEA Joint Committee Decision No. 91/2023 amends Annex II to the EEA Agreement to incorporate several Commission Implementing Regulations regarding plant protection products. These regulations concern the approval, amendment, and withdrawal of certain active substances. The decision entered into force on April 29, 2023, following required notifications.
Key Points / Main Content:
Amendments to Annex II:
* Chapter XV of Annex II to the EEA Agreement is amended.
* Point 13a is amended by deleting the text of the fortieth indent related to Commission Implementing Regulation EU No 1037/2012.
* Point 13a is amended by adding indents for Implementing Regulations EU 2022/456, EU 2022/489, EU 2022/496 and EU 2022/782.
Incorporation of Regulations:
* Commission Implementing Regulation (EU) 2022/456 on chitosan is incorporated.
* Commission Implementing Regulation (EU) 2022/489 amending approval periods for flubendiamide, L-ascorbic acid, spinetoram, and spirotetramat is incorporated.
* Commission Implementing Regulation (EU) 2022/496 approving Spodoptera exigua multicapsid nucleopolyhedrovirus (SeMNPV), isolate BV0004, is incorporated.
* Commission Implementing Regulation (EU) 2022/782 withdrawing approval for isopyrazam is incorporated.
Repeal and Replacement:
* Commission Implementing Regulation EU No 1037/2012 is repealed under the EEA Agreement.
* The text of point 13zs related to Commission Implementing Regulation EU No 1037/2012 is replaced by Commission Implementing Regulation EU 2022/782.
Authentic Texts:
* The Icelandic and Norwegian language texts of Implementing Regulations EU 2022/456, EU 2022/489, EU 2022/496, and EU 2022/782 are authentic.
Entry into Force:
* The Decision entered into force on April 29, 2023, after notifications under Article 103(1) of the EEA Agreement.
Impact Analysis:
Member States of the EEA:
*Impact: Must align national regulations with the updated Annex II of the EEA Agreement regarding technical regulations, standards, testing, and certification of plant protection products.
*Action Required: Review and implement the changes introduced by the incorporated Commission Implementing Regulations.
Plant Protection Product Manufacturers and Distributors:
*Impact: Affected by changes in the approval status and conditions for active substances like chitosan, flubendiamide, L-ascorbic acid, spinetoram, spirotetramat, Spodoptera exigua multicapsid nucleopolyhedrovirus (SeMNPV), and isopyrazam.
*Action Required: Adjust product formulations, marketing, and sales strategies to comply with the new regulations, including the withdrawal of products containing isopyrazam.
European Commission:
*Impact: Responsible for the ongoing monitoring and enforcement of regulations concerning plant protection products within the EEA.
*Action Required: Ensure that the incorporated regulations are effectively implemented and enforced across the EEA member states.
Key Entities Referenced
EEA Agreement: Agreement on the European Economic Area
Regulation EC No 1107/2009: Regulation of the European Parliament and of the Council concerning the placing of plant protection products on the market
Commission Implementing Regulation EU No 540/2011: Commission Implementing Regulation amending Regulation EC No 1107/2009
Commission Implementing Regulation EU 2022/456: Commission Implementing Regulation approving the basic substance chitosan
Commission Implementing Regulation EU 2022/489: Commission Implementing Regulation amending Implementing Regulation EU No 540/2011 as regards the approval periods of certain active substances
Commission Implementing Regulation EU 2022/496: Commission Implementing Regulation approving the low-risk active substance Spodoptera exigua multicapsid nucleopolyhedrovirus SeMNPV, isolate BV0004
Commission Implementing Regulation EU 2022/782: Commission Implementing Regulation withdrawing the approval of the active substance isopyrazam
Brussels: Location where the decision was made.
Official Journal EN
of the European Union L series
2023/2246 9.11.2023
DECISION OF THE EEA JOINT COMMITTEE No 91/2023
of 28 April 2023
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
[2023/2246]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98
thereof,
Whereas:
(1) Commission Implementing Regulation (EU) 2022/456 of 21 March 2022approving the basic substance chitosan in
accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the
placing of plant protection products on the market, and amending the Annex to Implementing Regulation (EU)
No 540/2011(1)is to be incorporated into the EEA Agreement.
(2) Commission Implementing Regulation (EU) 2022/489 of 25 March 2022amending Implementing Regulation (EU)
No 540/2011 as regards the approval periods of the active substances flubendiamide, L-ascorbic acid, spinetoram
and spirotetramat(2)is to be incorporated into the EEA Agreement.
(3) Commission Implementing Regulation (EU) 2022/496 of 28 March 2022approving the low-risk active substance
Spodoptera exigua multicapsid nucleopolyhedrovirus (SeMNPV), isolate BV-0004 in accordance with Regulation (EC)
No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products
on the market, and amending Commission Implementing Regulation (EU) No 540/2011(3) is to be incorporated
into the EEA Agreement.
(4) Commission Implementing Regulation (EU) 2022/782 of 18 May 2022 withdrawing the approval of the active
substance isopyrazam in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the
Council concerning the placing of plant protection products on the market, amending Commission Implementing
Regulation (EU) No 540/2011 and repealing Implementing Regulation (EU) No 1037/2012(4)is to be incorporated
into the EEA Agreement.
(5) Implementing Regulation (EU) 2022/782 repeals Commission Implementing Regulation (EU) No 1037/2012(5),
which is incorporated into the EEA Agreement and which is consequently to be repealed under the EEA Agreement.
(6) Annex II to the EEA Agreement should therefore be amended accordingly,
HAS ADOPTED THIS DECISION:
Article 1
Chapter XV of Annex II to the EEA Agreement shall be amended as follows:
1. Point 13a (Commission Implementing Regulation (EU) No 540/2011) is amended as follows:
(i) The text of the fortieth indent (Commission Implementing Regulation (EU) No 1037/2012) is deleted;
(1) OJ L 93, 22.3.2022, p. 138.
(2) OJ L 100, 28.3.2022, p. 7.
(3) OJ L 101, 29.3.2022, p. 1.
(4) OJ L 140, 19.5.2022, p. 3.
(5) OJ L 308, 8.11.2012, p. 15.
ELI: http://data.europa.eu/eli/dec/2023/2246/oj 1/3EN
OJ L, 9.11.2023
(ii) The following indents are added in point 13a:
‘— 32022 R 0456: Commission Implementing Regulation (EU) 2022/456 of 21 March 2022 (OJ L 93,
22.3.2022, p. 138),
— 32022 R 0489: Commission Implementing Regulation (EU) 2022/489 of 25 March 2022 (OJ L 100,
28.3.2022, p. 7),
— 32022 R 0496: Commission Implementing Regulation (EU) 2022/496 of 28 March 2022 (OJ L 101,
29.3.2022, p. 1),
— 32022 R 0782: Commission Implementing Regulation (EU) 2022/782 of 18 May 2022 (OJ L 140,
19.5.2022, p. 3).’.
2. The text of point 13zs (Commission Implementing Regulation (EU) No 1037/2012) is replaced by the following:
‘32022 R 0782: Commission Implementing Regulation (EU) 2022/782 of 18 May 2022withdrawing the approval of
the active substance isopyrazam in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of
the Council concerning the placing of plant protection products on the market, amending Commission Implementing
Regulation (EU) No 540/2011 and repealing Implementing Regulation (EU) No 1037/2012 (OJ L 140, 19.5.2022,
p. 3).’.
3. The following points are inserted after point 13zzzzzzzzzzzzv (Commission Implementing Regulation (EU) 2022/501):
‘13zzzzzzzzzzzzw. 32022 R 0456: Commission Implementing Regulation (EU) 2022/456 of 21 March 2022
approving the basic substance chitosan in accordance with Regulation (EC) No 1107/2009 of the
European Parliament and of the Council concerning the placing of plant protection products on
the market, and amending the Annex to Implementing Regulation (EU) No 540/2011 (OJ L 93,
22.3.2022, p. 138).
13zzzzzzzzzzzzx. 32022 R 0496: Commission Implementing Regulation (EU) 2022/496 of 28 March 2022
approving the low-risk active substance Spodoptera exigua multicapsid nucleopolyhedrovirus
(SeMNPV), isolate BV-0004 in accordance with Regulation (EC) No 1107/2009 of the European
Parliament and of the Council concerning the placing of plant protection products on the market,
and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 101, 29.3.2022,
p. 1).’
Article 2
The texts of Implementing Regulations (EU) 2022/456, (EU) 2022/489, (EU) 2022/496 and (EU) 2022/782 in the Icelandic
and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be
authentic.
Article 3
This Decision shall enter into force on 29 April 2023, provided that all the notifications under Article 103(1) of the EEA
Agreement have been made*.
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European
Union.
* No constitutional requirements indicated.
2/3 ELI: http://data.europa.eu/eli/dec/2023/2246/ojEN
OJ L, 9.11.2023
Done at Brussels, 28 April 2023.
For the EEA Joint Committee
The President
Nicolas VON LINGEN
ELI: http://data.europa.eu/eli/dec/2023/2246/oj 3/3